In breast and ovarian cancers, SIRT1 often correlates with aggressive behavior and therapy resistance, while in colon cancer, its role appears more context-dependent, sometimes contributing to genomic stability under specific conditions. This evidence concerns the gene SIRT1 and ovarian cancer.